Inoviq Ltd. Health Care

$0.850 0.030 (3.66%)

High $0.99	Low $0.84	Trades 317	Turnover $865,876	Volume 942,590
30 June 2023 at 4:10pm

Register to track IIQ and receive email alerts.

Market Cap (19-Sep) $38,009,376 (0th)	Close (30-Jun) $0.85 0 (0%)	Volume (30-Jun) 942,590	Shortsold (27-Oct) 800,001 (0.58%) (257th)
52w High $0.57	52w Low $0.250	P/E -	EPS -0.06

	Subject
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	1 (current) 2 3
	IIQ IIQ Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
	IIQ IIQ Ann: INOVIQ Investor Briefing
	IIQ IIQ Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
	IIQ IIQ Ann: ISEV Meeting Presentations
	IIQ IIQ Ann: Appendix 4C and Quarterly Activities Report - March 2023
	IIQ IIQ Ann: INOVIQ to present new EXO-NET data at ISEV Annual Meeting
	IIQ IIQ Ann: Change of Director's Interest Notice - Philip Powell
	IIQ IIQ Ann: Change of Director's Interest Notice - Philip Powell
	IIQ IIQ Ann: Appendix 4D and Half Year Financial Report
	IIQ IIQ Ann: Positive results for SubB2M Breast Cancer Test
	IIQ IIQ Ann: Notification regarding unquoted securities - IIQ
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	IIQ IIQ Ann: Appendix 4C & Quarterly Activities Report - December 2022
	IIQ IIQ Ann: Final Director's Interest Notice
	IIQ IIQ Ann: Resignation of Director
	IIQ IIQ Ann: Positive EXO-NET Results in Ovarian Cancer
	IIQ IIQ Ann: MST Access Diagnostics Forum Presentation
	IIQ IIQ Ann: Change in substantial holding
	IIQ IIQ Ann: Results of 2022 Annual General Meeting
	IIQ IIQ Ann: CEO AGM Presentation
	IIQ IIQ Ann: INOVIQ Settles Legal Proceedings
	IIQ IIQ Ann: Commercial and R&D Update
	IIQ IIQ Ann: Healthcare Conference Investor Presentation
	IIQ IIQ Ann: Appendix 4C - Statement pursuant to Listing Rule 4.7C.3
	IIQ IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report-September 2022
	IIQ IIQ Ann: Canadian Patent Granted for BARD1 Technology
	IIQ IIQ Ann: Investor Presentation
	IIQ IIQ Ann: Notice of Annual General Meeting
	IIQ IIQ Ann: Receipt of R&D Tax Incentive Refund
	IIQ IIQ Ann: INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
	IIQ IIQ Ann: Appendix 4G and Corporate Governance Statement
	IIQ IIQ Ann: Appointment/Resignation of CFO and Company Secretary
	IIQ IIQ Ann: Notification of cessation of securities - IIQ
	IIQ IIQ Ann: Notice required under listing rule 3.13.1
	IIQ IIQ Ann: 2022 Annual Report and update on results
	IIQ IIQ Ann: Appendix 4E and Preliminary Financial Report
	IIQ IIQ Ann: IIQ Investor Presentation
	IIQ IIQ Ann: INOVIQ Investor Briefing Invitation - June 2022 Quarter
	IIQ IIQ Ann: IIQ Appendix 4C & Quarterly Activities Report - June 2022
	IIQ IIQ Ann: Positive SubB2M IHC Results for Melanoma
	IIQ IIQ Ann: hTERT US Patent Granted
	IIQ IIQ Ann: INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
	IIQ IIQ Ann: SubB2M US Patent Grant and Program Update
	IIQ IIQ Ann: INOVIQ&University of Sydney Present New EXO-NET Data at ISEV
	IIQ IIQ Ann: Change of Director's Interest - Philip Powell
	IIQ IIQ Ann: IIQ Investor Presentation
	IIQ IIQ Ann: Change of Director's Interest - Dr Geoffrey Cumming
	IIQ IIQ Ann: Change of Director's Interest - Philip Powell
	IIQ IIQ Ann: INOVIQ Investor Briefing Invitation

Register to track IIQ and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.40	53,103	+0.01 (2.56%)
12-Sep	$0.39	23,874	0.00 (0.00%)
11-Sep	$0.39	58,846	-0.01 (2.50%)
05-Sep	$0.40	41,812	+0.01 (2.56%)
04-Sep	$0.39	60,992	-0.01 (2.50%)
03-Sep	$0.40	3,459	-0.01 (2.44%)
29-Aug	$0.41	8,939	0.00 (0.00%)
28-Aug	$0.41	5,037	+0.01 (2.50%)
22-Aug	$0.40	62,899	0.00 (0.00%)
21-Aug	$0.40	40,614	-0.03 (6.98%)
15-Aug	$0.43	96,776	-0.01 (1.15%)
14-Aug	$0.44	136,829	+0.04 (8.75%)
07-Aug	$0.40	45,205	+0.02 (3.90%)
31-Jul	$0.39	44,014	+0.02 (5.48%)
30-Jul	$0.37	37,390	0.00 (0.00%)
6 up, 5 down, and 4 flat days